The impact of increasing karyotypic complexity and evolution on survival in patients with CLL treated with ibrutinibAdam S. Kittai, Jennifer A. Woyach, David A. Bond et al.|Blood|2021Cited by 61
Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective StudyAdam S. Kittai, Philip A. Thompson, John C. Byrd et al.|Journal of Clinical Oncology|2024Cited by 43
Patient characteristics that predict Richter's transformation in patients with chronic lymphocytic leukemia treated with ibrutinibAdam S. Kittai, Jennifer A. Woyach, John C. Byrd et al.|American Journal of Hematology|2022Cited by 21